Single-Dose Azithromycin for Genital Lymphogranuloma Venereum Biovar Chlamydia trachomatis Infection in HIV-Infected Women in South Africa: An Observational Study.
Single-Dose Azithromycin for Genital Lymphogranuloma Venereum Biovar Chlamydia trachomatis Infection in HIV-Infected Women in South Africa: An Observational Study.
复制标题
DOI：
10.1097/olq.0000000000001243
复制
发表时间：
2021-02-01
影响因子：
3.1
通讯作者：
Medina-Marino A
中科院分区：
文献类型：
--
作者：
Peters RPH;Maduna L;Kock MM;McIntyre JA;Klausner JD;Medina-Marino A
We conducted an observational study of lymphogranuloma venereum (LGV) biovar Chlamydia trachomatis infection in HIV-infected women in South Africa. The LGV biovar was detected in vaginal specimens of 17/85 (20%) women with C. trachomatis infection; 29% were symptomatic. All cases were negative for the LGV biovar following single dose azithromycin. Lymphogranuloma venereum (LGV) biovar Chlamydia trachomatis infection was common in HIV-infected women in South Africa. No LGV biovar infection was detected at follow-up following single dose azithromycin treatment.
